生物合成
生物化学
化学
酿酒酵母
代谢工程
大肠杆菌
异源的
计算生物学
红豆杉
酵母
异源表达
生物
酶
立体化学
药物发现
代谢途径
中国仓鼠卵巢细胞
微生物
鉴定(生物学)
细胞培养
组合化学
作者
Chengshuai Yang,Zhenhua Li,Linjie Yu,Yan Wang,Liangzhen Zheng,Xing Yan,Wenping Wei,Bingtong Feng,Tong Zhang,Jianxu Li,Pingping Wang,Zhihua Zhou
出处
期刊:
[Cold Spring Harbor Laboratory]
日期:2026-08-03
标识
DOI:10.64898/2026.07.31.742161
摘要
ABSTRACT Taxol (paclitaxel) is a frontline anticancer drug widely applied for the treatment of breast, ovarian and lung cancers. Currently, its supply mainly relies on the semi-synthesis using baccatin III from Taxus plants. Heterologous biosynthesis of baccatin III in microorganisms offers a promising solution to alleviate global Taxol supply shortage, but remains challenging due to pathway complexity. Here, we report a novel taxusin-mediated biosynthetic pathway for baccatin III production via the identification of C13 deacetylase, elucidation of the exact sequence underlying C1 hydroxylation, and stepwise enzymatic functional validation. Through protein engineering of the promiscuous C1 and C5 hydroxylases, coupled with the distribution of pathway modules in Saccharomyces cerevisiae and Escherichia coli , we achieved the de novo biosynthesis of baccatin III. Collectively, our findings remodel the current biosynthetic framework governing the formation of Taxol precursors and highlight the great potential of microbial cell factories for the production of complex plant-derived therapeutic compounds. Highlights • Discovery of C13 deacetylase reveals a novel biosynthetic route to baccatin III via taxusin • Stepwise verification of the complete biosynthetic route to baccatin III through taxusin and baccatin VI • Single-site mutation reversed the product selectivity of T1OH and converted T5OH into a specific taxoid C5 hydroxylase • Complete biosynthesis of baccatin III in engineered microbes
科研通智能强力驱动
Strongly Powered by AbleSci AI